Conard Wai's Insider Trades & SAST Disclosures
Conard Wai's most recent trade in Clover Health Investments Corp - Ordinary Shares - Class A was a trade of 26,593 Class A Common Stock done at an average price of $3.4 . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Conard Wai.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Clover Health Investments ... | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 30 Apr 2025 | 26,593 | 3,236,946 | - | 3.4 | 90,416 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.66 per share. | 14 Mar 2025 | 80,524 | 3,263,539 | - | 3.7 | 294,718 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.39 per share. | 31 Jan 2025 | 24,470 | 3,344,063 | - | 4.4 | 107,423 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.11 per share. | 14 Dec 2024 | 98,217 | 3,368,533 | - | 3.1 | 305,455 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.12 per share. | 31 Oct 2024 | 111,496 | 3,466,750 | - | 4.1 | 459,364 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | CEO, Counterpart Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 726,114 | 3,578,246 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Conard Wai | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 189,934 | 3,043,529 | - | 0 | Class A Common Stock | |
| Clover Health Investments ... | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 98,217 | 2,852,132 | - | 3.0 | 293,669 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 13 Sep 2024 | 93,180 | 2,950,349 | - | 3.0 | 278,608 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 14 Jun 2024 | 69,148 | 2,853,595 | - | 1.1 | 75,371 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.73 per share. | 14 Mar 2024 | 74,396 | 2,922,743 | - | 0.7 | 54,309 | Class A Common Stock |
| Clover Health Investments ... | Wai Conard | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 14 Dec 2023 | 96,086 | 2,997,139 | - | 1 | 96,086 | Class A Common Stock |
| Clover Health Investments ... | Conard Wai | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 14 Jun 2023 | 86,763 | 2,749,311 | - | 0.9 | 81,557 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges